MENU
+Compare
HYLG
ETF ticker: NYSE ARCA
AS OF
Jan 17 closing price
Price
$24.07
Change
-$0.03 (-0.12%)
Net Assets
2.89M

HYLG stock forecast, quote, news & analysis

Category: @Trading
HYLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for HYLG with price predictions
Jan 08, 2025

HYLG's RSI Indicator climbs out of oversold territory

The RSI Oscillator for HYLG moved out of oversold territory on January 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 11 similar instances when the indicator left oversold territory. In of the 11 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on HYLG as a result. In of 37 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HYLG just turned positive on December 31, 2024. Looking at past instances where HYLG's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYLG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HYLG entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P Health Care Select Sector Half BuyWrite Index. The index measures the performance of a partially covered call strategy that holds a theoretical portfolio of the securities of the Health Care Select Sector Index. The fund invests in the securities reflected in the index or in investments (including other ETFs) that have economic characteristics that are substantially identical to the economic characteristics of such component securities and cannot invest directly in the index itself. It is non-diversified.

Market Cap

The average market capitalization across the Global X Health Care Cvrd Cll&Gr ETF ETF is 88.77B. The market cap for tickers in the group ranges from 9.7B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is HSIC at 9.7B.

High and low price notable news

The average weekly price growth across all stocks in the Global X Health Care Cvrd Cll&Gr ETF ETF was 1%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was -4%. CVS experienced the highest price growth at 10%, while MRNA experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Global X Health Care Cvrd Cll&Gr ETF ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was -10% and the average quarterly volume growth was 36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 58
Price Growth Rating: 50
SMR Rating: 61
Profit Risk Rating: 57
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
HYLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Derivative Income
Address
Global X Funds600 Lexington Avenue, 20th FloorNew York
Phone
+1 8884938631
Web
www.globalxfunds.com